Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrations-Reference-Cited by-同舟云学术

Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrations

Published:1992-11 Issue:5 Volume:124 Page:1270-1276
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Flapan A.D.,Shaw T.R.D.,Edwards C.R.W.,Davies E.,Williams B.C.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Immediate and sustained haemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor;Ader;Circulation,1980

2. A placebo-controlled trial of captopril in refractory chronic congestive heart failure;J Am Coll Cardiol,1983

3. Captopril in heart failure: a double blind controlled trial;Cleland;Br Heart J,1984

4. Relationship of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure;Dzau;Circulation,1981

5. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics;Bayliss;Br Heart J,1987

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure;Circulation;2001-10-30

2. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure*;Clinical Pharmacology & Therapeutics;1996-06

3. THE INFLUENCE OF CAPTOPRIL AND NALOXONE ON THE VALSALVA MANOEUVRE AND SYSTOLIC TIME INTERVALS IN HEALTHY VOLUNTEERS;Clinical and Experimental Pharmacology and Physiology;1994-04

4. Effects of Spiraprilat, an Angiotensin-Converting Enzyme Inhibitor, on Anesthetized Dogs in a New Model of Acute Left Ventricular Failure;Journal of Cardiovascular Pharmacology;1993-10